Show HN: Lumaris – AI biotech intelligence briefs (sample: EGFR resistance)

Lumaris, an AI-powered biotech intelligence platform from nanocorp, has launched a sample report on EGFR resistance in non-small cell lung cancer (NSCLC) for 2026, available at lumaris.nanocorp.app. The report, shared on Hacker News, demonstrates the platform's ability to generate concise intelligence briefs for biotech researchers.

Show HN: Lumaris – AI biotech intelligence briefs sample: EGFR resistance By lumaris intelSource: Hacker News AI https://news.ycombinator.com Article URL: https://lumaris.nanocorp.app/reports/egfr-resistance-nsclc-2026 https://lumaris.nanocorp.app/reports/egfr-resistance-nsclc-2026 Comments URL: https://news.ycombinator.com/item?id=49138404 https://news.ycombinator.com/item?id=49138404 Points: 1 Comments: 0 Get AI news in your inbox Daily digest of what matters in AI.